Collegium Pharmaceutical (COLL) Stock Chart & Stock Price History → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free COLL Stock Alerts $35.95 +1.21 (+3.48%) (As of 10:33 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Collegium Pharmaceutical Stock Price Performance5 Day Performance-0.09%1 Month Performance-12.54%3 Month Performance+5.40%6 Month Performance+63.41%Year-To-Date Performance+12.87%1 Year Performance+50.59% Receive COLL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry COLL Stock Chart for Tuesday, April, 23, 2024 COLL Chart by TradingView Collegium Pharmaceutical Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/22/2024$34.84$34.74-0.29%$35.30$34.55414,728 shs$1.14 billion04/19/2024$34.77$34.84+0.20%$35.34$34.24325,319 shs$1.14 billion04/18/2024$35.45$34.77-1.92%$35.47$34.69203,938 shs$1.14 billion04/17/2024$35.40$35.45+0.14%$35.73$34.83256,530 shs$1.16 billion04/16/2024$35.14$35.40+0.74%$35.81$34.75323,773 shs$1.16 billion04/15/2024$35.71$35.14-1.60%$35.83$35.12366,302 shs$1.15 billion Get the Latest News and Ratings for COLL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 04/12/2024$36.39$35.71-1.87%$36.51$35.47380,381 shs$1.17 billion04/11/2024$37.99$36.39-4.21%$37.97$35.72462,878 shs$1.19 billion04/10/2024$38.79$37.99-2.06%$38.89$37.95311,406 shs$1.24 billion04/09/2024$39.42$38.79-1.60%$39.53$38.41204,177 shs$1.24 billion04/08/2024$39.99$39.42-1.43%$40.02$38.89235,209 shs$1.26 billion04/05/2024$39.30$39.99+1.76%$40.24$39.05384,715 shs$1.28 billion04/04/2024$39.45$39.30-0.38%$40.49$39.17366,245 shs$1.26 billion04/03/2024$38.40$39.45+2.73%$39.46$38.24261,625 shs$1.26 billion04/02/2024$38.88$38.40-1.23%$39.03$38.12335,174 shs$1.23 billion04/01/2024$38.82$38.88+0.15%$38.97$37.63351,382 shs$1.24 billion03/29/2024$38.82$38.82$40.95$38.59613,299 shs$1.24 billion03/28/2024$40.91$38.82-5.11%$40.95$38.59613,299 shs$1.24 billion03/27/2024$39.93$40.91+2.45%$40.91$39.97362,313 shs$1.31 billion03/26/2024$40.16$39.93-0.57%$40.32$39.44335,554 shs$1.28 billion03/25/2024$39.72$40.16+1.11%$40.59$39.55273,351 shs$1.28 billion03/22/2024$39.66$39.72+0.15%$39.96$39.13319,417 shs$1.27 billion03/21/2024$38.79$39.66+2.24%$39.80$38.47584,073 shs$1.27 billion03/20/2024$37.96$38.79+2.19%$38.88$37.29519,232 shs$1.24 billion03/19/2024$39.35$37.96-3.53%$39.37$37.74855,053 shs$1.21 billion03/18/2024$39.09$39.35+0.67%$39.90$38.86502,272 shs$1.26 billion03/15/2024$38.03$39.09+2.79%$39.45$37.641.99 million shs$1.25 billion03/14/2024$38.30$38.03-0.70%$38.33$37.21383,451 shs$1.22 billion03/13/2024$37.40$38.30+2.41%$38.48$37.01337,755 shs$1.22 billion03/12/2024$37.50$37.40-0.27%$37.72$36.79310,737 shs$1.20 billion03/11/2024$37.60$37.50-0.27%$37.97$36.97495,658 shs$1.20 billion03/08/2024$37.20$37.60+1.08%$38.39$37.34427,986 shs$1.20 billion03/07/2024$36.68$37.20+1.42%$37.23$36.46332,330 shs$1.19 billion03/06/2024$36.31$36.68+1.02%$36.92$35.91403,353 shs$1.17 billion03/05/2024$37.03$36.31-1.94%$37.09$35.92318,168 shs$1.16 billion03/04/2024$37.13$37.03-0.27%$37.65$36.61294,944 shs$1.18 billion03/01/2024$36.71$37.13+1.14%$37.50$36.50418,575 shs$1.19 billion02/29/2024$36.57$36.71+0.38%$37.37$36.23512,447 shs$1.17 billion02/28/2024$36.79$36.57-0.60%$37.00$35.72299,831 shs$1.17 billion02/27/2024$36.56$36.79+0.63%$37.79$36.41706,628 shs$1.18 billionDon’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him02/26/2024$36.35$36.56+0.58%$37.75$35.52908,149 shs$1.17 billion02/23/2024$32.81$36.35+10.79%$36.35$33.301.01 million shs$1.19 billion02/22/2024$31.76$32.81+3.31%$33.00$31.73779,338 shs$1.07 billion02/21/2024$32.08$31.76-1.00%$32.42$31.34386,896 shs$1.04 billion02/20/2024$32.58$32.08-1.53%$32.20$31.48270,788 shs$1.05 billion02/19/2024$32.58$32.58$34.18$32.31354,400 shs$1.06 billion02/16/2024$33.95$32.58-4.04%$34.18$32.31354,492 shs$1.06 billion02/15/2024$32.88$33.95+3.25%$34.05$33.16334,349 shs$1.11 billion02/14/2024$32.19$32.88+2.14%$32.92$32.17213,986 shs$1.07 billion02/13/2024$33.70$32.19-4.48%$33.18$31.97350,935 shs$1.05 billion02/12/2024$33.48$33.70+0.66%$34.15$33.56347,969 shs$1.10 billion02/09/2024$33.34$33.48+0.42%$33.74$33.31221,309 shs$1.09 billion02/08/2024$33.21$33.34+0.39%$33.35$32.75366,679 shs$1.09 billion02/07/2024$33.24$33.21-0.09%$33.53$33.06477,829 shs$1.08 billion02/06/2024$33.09$33.24+0.45%$33.44$32.99163,860 shs$1.08 billion02/05/2024$32.84$33.09+0.76%$33.33$32.44273,719 shs$1.08 billion02/02/2024$33.47$32.84-1.88%$33.44$32.74164,660 shs$1.07 billion02/01/2024$32.96$33.47+1.55%$33.53$32.73204,216 shs$1.09 billion01/31/2024$33.45$32.96-1.46%$34.24$32.87334,410 shs$1.07 billion01/30/2024$33.89$33.45-1.30%$33.87$33.07163,190 shs$1.09 billion01/29/2024$33.18$33.89+2.14%$33.89$32.67201,554 shs$1.11 billion01/26/2024$33.49$33.18-0.93%$33.80$33.04185,232 shs$1.08 billion01/25/2024$33.14$33.49+1.06%$33.68$33.09163,616 shs$1.09 billion01/24/2024$32.96$33.14+0.55%$33.53$32.93256,618 shs$1.08 billion01/23/2024$33.51$32.96-1.64%$33.84$32.44277,777 shs$1.07 billion01/22/2024$32.99$33.51+1.58%$33.62$33.05312,866 shs$1.09 billion Related Companies: OCUL Stock Chart XNCR Stock Chart PRTA Stock Chart ABCL Stock Chart MIRM Stock Chart DCPH Stock Chart CNTA Stock Chart IMNM Stock Chart MNKD Stock Chart KNSA Stock Chart Receive COLL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:COLL) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.